在2023年美国心脏协会科学年会(AHA 2023)上,来自瑞典乌普萨拉大学的Stefan James教授公布了DAPA-MI研究的主要结果:证明达格列净可以改善既往无糖尿病和慢性心力衰竭的心肌梗死患者的心脏代谢终点(降低新发2型糖尿病风险和减轻体重)[1]。 ...
CardiologyempagliflozindapagliflozinSGLT2 inhibitorsacute myocardial infarctionEMPACT-MI TrialDAPA-MI Trialdoi:10.1080/17512433.2024.2390921Muhammad Adnan ZamanSidra KalsoomExpert Review of Clinical Pharmacology
达格列净Farxiga(dapaglifozin) [ 人气:117 | 日期: 2022-04-19 |返回|打印] 药品名称:达格列净Farxiga(dapaglifozin) 药品别名:dapaglifozin 英文名:dapaglifozin 药品价格:HK$ 请咨询微信客服 研发公司:Astrazeneca Ab 适用症:Ⅱ型糖尿病 型号规格:5mg,10mg...
🎚️ Dapa Music DJ MIX 002 _ Vocal House _ Deep House _ Best Music _ Lingerie and Bikini Fashion 🎚️ http://t.cn/A6WdWLKF
The dapagliflozin in patients with myocardial infarction (DAPA-MI) trial in perspectiveSodium-glucose cotransporter-2 (SGLT2) inhibitors have shown a reduction in major adverse cardiovascular events (MACE), defined as cardiovascular death, myocardial infarction (MI), or stroke,...